Sign In
Buy ADMA
$8.69
+0.120 (+1.40%)
At Close: Jun 23, 2026
NEW YORK--(BUSINESS WIRE)---- $ADMA #ADMA--ADMA Biologics Investors are Notified the Company is being Investigated for Securities Fraud after 29% Stock Drop.
Bragar Eagel & Squire, P.C. Urges ADMA Biologics, Inc. (NASDAQ:ADMA) Investors to Contact the Firm Regarding Ongoing Investigation
04:57pm, Wednesday, 08'th Apr 2026
Bragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In ADMA To Contact Him Directly To Discuss Their Options
NEW YORK, April 08, 2026 (GLOBE NEWSWIRE) -- Lowey Dannenberg P. C. , a preeminent law firm in obtaining redress for consumers and investors, is investigating ADMA Biologics (NASDAQ: ADMA) ("ADMA Biol
NEW YORK, April 08, 2026 (GLOBE NEWSWIRE) -- Leading securities law firm Bleichmar Fonti & Auld LLP announces an investigation into ADMA Biologics, Inc. (NASDAQ:ADMA) for potential violations of the
ADMA Biologics: The Short Report Is The Noise, Not The Signal
12:23pm, Tuesday, 07'th Apr 2026
ADMA Biologics (ADMA) remains a Buy after a 40% stock decline, with Asceniv's niche demand and premium pricing intact. Concerns about rising DSO are mitigated by falling distributor inventory and stro
NEW YORK, April 06, 2026 (GLOBE NEWSWIRE) -- Leading securities law firm Bleichmar Fonti & Auld LLP announces an investigation into ADMA Biologics, Inc. (NASDAQ:ADMA) for potential violations of the f
Allspring Global Investments Holdings LLC Decreases Stock Position in ADMA Biologics Inc $ADMA
03:25am, Monday, 06'th Apr 2026
Allspring Global Investments Holdings LLC trimmed its position in shares of ADMA Biologics Inc (NASDAQ: ADMA) by 68.3% in the undefined quarter, according to its most recent disclosure with the Securi
Investigation Opened on Behalf of ADMA Biologics, Inc. (ADMA) Shareholders - Contact Levi & Korsinsky
12:36am, Monday, 06'th Apr 2026
New York, New York--(Newsfile Corp. - April 6, 2026) - Levi & Korsinsky notifies investors that it has commenced an investigation into ADMA Biologics, Inc. (NASDAQ: ADMA) ("ADMA Biologics, Inc.") con
Contrasting ADMA Biologics (NASDAQ:ADMA) and Cardiac Biotech Solutions (OTCMKTS:CBSC)
01:35am, Sunday, 05'th Apr 2026
Cardiac Biotech Solutions (OTCMKTS:CBSC - Get Free Report) and ADMA Biologics (NASDAQ: ADMA - Get Free Report) are both medical companies, but which is the better business? We will contrast the two bu
NEW YORK, April 03, 2026 (GLOBE NEWSWIRE) -- Leading securities law firm Bleichmar Fonti & Auld LLP announces an investigation into ADMA Biologics, Inc. (NASDAQ:ADMA) for potential violations of the
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of ADMA Biologics, Inc. - ADMA
09:44pm, Thursday, 02'nd Apr 2026
NEW YORK, April 2, 2026 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of ADMA Biologics, Inc. ("ADMA" or the "Company") (NASDAQ: ADMA). Such investors are advised to c
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of ADMA Biologics, Inc. - ADMA
10:00am, Thursday, 02'nd Apr 2026
NEW YORK, April 2, 2026 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of ADMA Biologics, Inc. ("ADMA" or the "Company") (NASDAQ: ADMA). Such investors are advised to c
ADMA INVESTOR ALERT: Kirby McInerney LLP Investigates Potential Claims Involving ADMA Biologics, Inc.
08:00pm, Wednesday, 01'st Apr 2026
NEW YORK--(BUSINESS WIRE)--The law firm of Kirby McInerney LLP continues its investigation on behalf of ADMA Biologics, Inc. (“ADMA” or the “Company”) (NASDAQ:ADMA) investors concerning the Co
Rosen Law Firm Encourages ADMA Biologics, Inc. Investors to Inquire About Securities Class Action Investigation – ADMA
07:00pm, Wednesday, 01'st Apr 2026
NEW YORK--(BUSINESS WIRE)--Why: Rosen Law Firm, a global investor rights law firm, announces an investigation of potential securities claims on behalf of shareholders of ADMA Biologics, Inc. (NYSE: BC
SAN FRANCISCO, April 01, 2026 (GLOBE NEWSWIRE) -- Investors in ADMA Biologics, Inc. (NASDAQ: ADMA) saw the price of their shares slide over 16% on March 24, 2026 on short seller Culper Research's repo
